immunoistochimica
Componenti
- Maria S. Scalzo (Tecnico)
- Stefania Bolla (Tecnico)
Contatti
- 0116334388
- Scrivi a tutti i componenti
Attività
Il laboratorio di immunoistochimica ha lunga esperienza nella standardizzazione e messa a punto di metodiche per anticorpi commerciali e non, anche mediante l’utilizzo di Tissue Microarray (TMA). E’ laboratorio di riferimento per i Controlli di Qualità regionali relativi alla standardizzazione dei protocolli e della lettura dei fattori prognostici del carcinoma della mammella.
Prodotti della ricerca
Selezione di pubblicazioni:
Senetta R, Duregon E, Sonetto C, Spadi R, Mistrangelo M, Racca P, Chiusa L, Munoz FH, Ricardi U, Arezzo A, Cassenti A, Castellano I, Papotti M, Morino M, Risio M, Cassoni P. (2015) YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study. PloS one 10(4) e0123759 [DOI PMID]
Duregon E, Cassenti A, Pittaro A, Ventura L, Senetta R, Ruda R, Cassoni P. (2015) Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds. Neuro-oncology 17(5) 663-9 [DOI PMID]
Balmativola D, Marchio C, Maule M, Chiusa L, Annaratone L, Maletta F, Montemurro F, Kulka J, Figueiredo P, Varga Z, Liepniece-Karele I, Cserni G, Arkoumani E, Amendoeira I, Callagy G, Reiner-Concin A, Cordoba A, Bianchi S, Decker T, Glaser D, Focke C, van Diest P, Grabau D, Lips E, Wesseling J, Arisio R, Medico E, Wells C, Sapino A. (2014) Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study. Breast cancer research and treatment 148(3) 511-23 [DOI PMID]
Castellano I, Chiusa L, Vandone AM, Beatrice S, Goia M, Donadio M, Arisio R, Muscara F, Durando A, Viale G, Cassoni P, Sapino A. (2013) A simple and reproducible prognostic index in luminal ER-positive breast cancers. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 24(9) 2292-7 [DOI PMID]
Mistrangelo M, Senetta R, Racca P, Castellano I, Chiusa L, Bello M, Ricardi U, Morino M, Cassoni P. (2013) A novel biomarker-based analysis reliably predicts nodal metastases in anal carcinoma: preliminary evidence of therapeutic impact. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 15(11) 1382-91 [DOI PMID]
Senetta R, Miracco C, Lanzafame S, Chiusa L, Caltabiano R, Galia A, Stella G, Cassoni P. (2011) Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes. Neuro-oncology 13(2) 176-83 [DOI PMID]
Marchio C, Dowsett M, Reis-Filho JS. (2011) Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box. BMC medicine 9 41 [DOI PMID]
Castellano I, Allia E, Accortanzo V, Vandone AM, Chiusa L, Arisio R, Durando A, Donadio M, Bussolati G, Coates AS, Viale G, Sapino A. (2010) Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers. Breast cancer research and treatment 124(3) 607-17 [DOI PMID]